JPS6244259A - Visible light curable medical gypsum - Google Patents

Visible light curable medical gypsum

Info

Publication number
JPS6244259A
JPS6244259A JP60182530A JP18253085A JPS6244259A JP S6244259 A JPS6244259 A JP S6244259A JP 60182530 A JP60182530 A JP 60182530A JP 18253085 A JP18253085 A JP 18253085A JP S6244259 A JPS6244259 A JP S6244259A
Authority
JP
Japan
Prior art keywords
visible light
cast
resin
curable
light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60182530A
Other languages
Japanese (ja)
Inventor
中林 正彦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP60182530A priority Critical patent/JPS6244259A/en
Publication of JPS6244259A publication Critical patent/JPS6244259A/en
Pending legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 、II    f−日 本発明は可視光線によって硬化する医療用FRPギプス
に間する。
DETAILED DESCRIPTION OF THE INVENTION The Japanese invention relates to a medical FRP cast that is cured by visible light.

人体の骨折、脱臼等の医学的治療において、ギプス処置
が行われるが、この目的に使用するギプスは石膏と綿布
の組み合わせのものが圧倒的に多い0石膏ギプスは価格
が安い、施工が簡単である無害でありかつ必要強度が得
られるなどの利点はあるが9反面硬化が遅い、必要強度
を得るためにはかなりの厚さが必要である。患者にとっ
て重すぎる、乾燥までに時間がかかりすぎ、この間患者
は水分の蒸発潜熱のため、2−3日の乾燥期間中患部の
寒気に耐えなければならない、さらに通気性が殆ど無い
ため、患部のかぶれ等ギプス装着期間中かなりの苦痛に
耐えることを強いられるのが現状である。
Plaster casts are used in the medical treatment of human fractures, dislocations, etc., but overwhelmingly the casts used for this purpose are a combination of plaster and cotton cloth.Plaster casts are cheap and easy to construct. Although it has the advantage of being harmless and providing the necessary strength, it is slow to cure and requires a considerable thickness to obtain the required strength. It is too heavy for the patient, it takes too long to dry, the patient has to endure the coldness of the affected area during the drying period of 2-3 days due to the latent heat of vaporization of water, and there is almost no ventilation, so the affected area Currently, patients are forced to endure considerable pain such as rashes while wearing the cast.

このような欠点を有する石膏ギプスにたいして最近では
高分子、とくにプラスチック材料を応用したギプスの開
発研究が一部に見られるようになってきた2例えばヨー
ロッパでは、ガラス繊維あるいは綿布に、湿気硬化型の
ポリウレタン樹脂を含浸したものが一部で使われ始めて
いる。この種ギプスは水分速量のためプラスチックフィ
ルムに密封された状態で市販されており、実用時には開
封後、水に浸せきして吸水させ、ポリウレタン樹脂と水
の反応を利用して硬化させ、いわゆるポリウレタンを結
合剤とするFRPのギプスである。
In response to these drawbacks of plaster casts, some research has recently begun to develop casts made of polymers, especially plastics2.For example, in Europe, moisture-curing casts made of glass fiber or cotton cloth have been developed. Products impregnated with polyurethane resin are beginning to be used in some areas. This type of cast is commercially available sealed in a plastic film due to its moisture content, and in practical use, after opening, it is immersed in water to absorb water, and cured using the reaction between polyurethane resin and water. This is an FRP cast made of FRP as a binder.

この種ギプスは軽量2通気性等において、効果を発揮す
るが、硬化に15−30分とかなりの時間がかるうえに
2強度的にやや剛性が足りないなごの欠点を有すると言
われている。
This type of cast is effective in terms of light weight, breathability, etc., but it takes a considerable amount of time to harden (15-30 minutes), and it is said to have the drawbacks of being somewhat lacking in rigidity in terms of strength. .

さらに他方では紫外線硬化型のアクリル樹脂の配合物を
ガラス繊維や他の繊維状補強材と絹合わせて石膏ギプス
の代わりとする開発も一部では研究されている。その理
由は紫外線による硬化方法はラジカル開始剤が容易に人
手できること、硬化が早いこと、施工が簡単であること
9強度の高いギプスが得られることの利点があるためで
ある。
On the other hand, some research is also underway to develop UV-curable acrylic resin formulations combined with glass fibers or other fibrous reinforcing materials to replace plaster casts. The reason for this is that the ultraviolet curing method has the advantages of being able to use a radical initiator easily, curing quickly, being easy to apply, and producing a cast with high strength.

しかし紫外線を用いると小児や老人あるいは過敏性の体
質の人への治療では、皮膚かぶれ、炎症などの弊害がと
きには発生し2問題であるとされている。現に歯科関係
では紫外線硬化方法は禁止の方向に向かっている。
However, when ultraviolet rays are used to treat children, the elderly, or people with hypersensitivity, adverse effects such as skin irritation and inflammation sometimes occur, which is considered to be two problems. In fact, there is a trend towards banning ultraviolet curing methods in the dental field.

そこで本発明は光硬化型のギプスにおいて紫外線の代わ
りに人体に無害の可視光線を利用して硬化するギプス系
の研究を行った結果、前記紫外線硬化型のギプスが有し
ている長所はそのままで。
Therefore, as a result of research into a photo-curable cast that uses visible light, which is harmless to the human body, instead of ultraviolet light, the present invention has found that the advantages of the ultraviolet-curable cast are retained. .

人体へ全く無害のギプスの開発に成功した。以下その発
明の詳細について述べる。
We have succeeded in developing a cast that is completely harmless to the human body. The details of the invention will be described below.

光硬化型の樹脂としてよく知られている樹脂としては不
飽和ポリエステル樹脂、多官能アクリル樹脂、アクリル
−ウレタン樹脂、エポキシアクリレート樹脂などがある
。これらはいずれも過酸化物の存在下で架橋反応を起こ
し、熱硬化性の樹脂となる。最近このような硬化反応を
光重合間始剤の存在下で光を用いて行うことが公知とな
ってきている。しかしそのほとんどはエネルギレベルの
高い紫外線を用いて行う方法である。この方法では前記
人体への影響が問題となってくる1本発明では可視光線
でも光重合反応による樹脂の硬化が行えうれば人体に無
害のギプスができるという発想のもとに研究に取り組ん
だ、その結果、熱硬化性エポキシアクリレート樹脂に、
可視光線で容易に硬化機能を有する実施例に掲げたよう
な光重合間始剤を用いると、紫外線硬化法と全く変わら
ない形でギプス用結合材とすることができ、得られたギ
プスの強度は優れたものであった。
Well-known photocurable resins include unsaturated polyester resins, polyfunctional acrylic resins, acrylic-urethane resins, and epoxy acrylate resins. All of these undergo a crosslinking reaction in the presence of peroxide and become thermosetting resins. Recently, it has become known to carry out such a curing reaction using light in the presence of a photopolymerization initiator. However, most of these methods use high-energy ultraviolet light. With this method, the above-mentioned effect on the human body is a problem.In the present invention, we conducted research based on the idea that if the resin could be cured by a photopolymerization reaction even with visible light, it would be possible to create a cast that is harmless to the human body. As a result, thermosetting epoxy acrylate resin,
By using a photopolymerization initiator such as the one listed in the example that has the ability to harden easily with visible light, it is possible to create a binder for casts in a way that is no different from the ultraviolet curing method, and the strength of the resulting cast can be increased. was excellent.

この種樹脂系はガラス繊維等の繊維状補強材と密着性が
高く、他の多官能アクリル樹脂を使用した例に比べて強
度的に優れたFRPギプスとなることが判明した。
It has been found that this type of resin system has high adhesion to fibrous reinforcing materials such as glass fibers, resulting in FRP casts with superior strength compared to examples using other polyfunctional acrylic resins.

樹脂組成体とwA繊維状補強材らなるギプス素材は実用
までの保存性を確保するために光の遮閉下で保存される
。この目的のためには光遮閉能のあるプラスチックフィ
ルムの袋、あるいはその他の適当な容器中に保存する。
The cast material made of the resin composition and the wA fibrous reinforcing material is stored under light shielding to ensure its shelf life until practical use. For this purpose, they are stored in light-tight plastic film bags or other suitable containers.

ギプスの治療に際しては、ギプス素材を容器から取り出
し、患者の患部に適当な保護布を介して適当量を巻きつ
け、可視光線を照射する。配合が適切であれば、10−
60秒で組成物は硬化し、十分な強度が得られる。
When treating a cast, the cast material is removed from the container, an appropriate amount is wrapped around the affected area of the patient through a suitable protective cloth, and visible light is irradiated. If the formulation is appropriate, 10-
The composition hardens in 60 seconds and has sufficient strength.

本発明のギプスは繊維状物への塗布量を調節することに
よって、十分な通気性が得られ、また補強材のm維を選
択することによって著しく軽量でしかも強度の高いギプ
スとすることができる。また石膏ギプスと異なって乾燥
までの患者の不快感を完全に除くこともできるといった
効果があり。
The cast of the present invention can obtain sufficient air permeability by adjusting the amount applied to the fibrous material, and can be made extremely lightweight and strong by selecting m-fiber as the reinforcing material. . Also, unlike plaster casts, it has the effect of completely eliminating the patient's discomfort until it dries.

さらに治療時には、可視光線を使用するので2人体に対
する弊害も全く発生しないと言える。以下本発明を実施
例を挙げてさらに詳しく説明する。
Furthermore, since visible light is used during treatment, it can be said that there will be no harmful effects on the human body at all. The present invention will be explained in more detail below by giving examples.

実Ju辻−」− エポキシアクリレート(エピコート828アクリレ−)
)100gに重合開始剤としてカンファーキノン 4g
ベンジルジメチルケタール 12g、ジメチールアミノ
エチールメタクリレート5gを加え、この組成物を幅7
0mm、長さ1000mmのガラス繊維クロスに含浸さ
せ、黒色のプラスチック袋に保存した。
Miju Tsuji - Epoxy acrylate (Epicote 828 acrylate)
) 100g and 4g of camphorquinone as a polymerization initiator.
12 g of benzyl dimethyl ketal and 5 g of dimethylaminoethyl methacrylate were added, and the composition was
A glass fiber cloth with a diameter of 0 mm and a length of 1000 mm was impregnated and stored in a black plastic bag.

患者の患部に綿の保護布を巻き、この上に袋より取り出
した本組成のギプス素材を2重にまきつけさらにこの上
に透明のプラスチックフィルムをまきつけ、可視光線ラ
ンプから光を照射した。ギプスは15秒で完全に硬化し
た。この後余分なプラスチックフィルムを除去すると施
工は修了である。このものは十分な強度および通気性を
有し。
A cotton protective cloth was wrapped around the affected area of the patient, and a cast material of the present composition taken out from the bag was wrapped in two layers on top of the cloth, a transparent plastic film was further wrapped on top of this, and light was irradiated from a visible light lamp. The cast completely hardened in 15 seconds. After this, remove the excess plastic film and the installation is complete. This material has sufficient strength and breathability.

重量は石膏の10分の1以下であった。The weight was less than one-tenth that of gypsum.

実」I穎−1− 実施例1のエポキシアクリレート 75gにトリメチロ
ールプロハントリアクリレート 25gの混合物にかえ
、同様の実験を行った。この例においても実用的なギプ
ス成形できた。
A similar experiment was carried out using a mixture of 75 g of epoxy acrylate in Example 1 and 25 g of trimethylol propane triacrylate. In this example as well, a practical cast could be formed.

宜J1乱−」L 実施例1のエピコート828アクリレートをメタクリル
酸グリシジル樹脂に代えて同様の実験を行った。得られ
たギプスは衝撃特性に優れたものであった。
A similar experiment was conducted by replacing Epicote 828 acrylate in Example 1 with glycidyl methacrylate resin. The obtained cast had excellent impact properties.

実Jl性−コし 実施例1の繊維状補強材を合成繊維、あるいは綿布に代
えて実験した。ガラス繊維はど強度は得られできなかっ
たが、十分実用にたえる程度のギプスが得られた。
Experiments were conducted in which the fibrous reinforcing material of Example 1 was replaced with synthetic fibers or cotton cloth. Although the strength of the glass fibers could not be obtained, a cast that could be used for practical purposes was obtained.

Claims (1)

【特許請求の範囲】 1、ラジカル反応によって硬化する架橋型樹脂に可視光
線で硬化する機能を有するラジカル開始剤および助剤を
混入し、この種樹脂配合物を各種繊維状補強材に含浸し
、使用時には人体に短時間では無害な領域の光、例えば
波長が380−550ミリミクロンを照射し、目的の形
状に樹脂を硬化させ成形して使用する可視光線硬化型樹
脂ギプス。 2、前記架橋型樹脂が、エポキシアクリレート樹脂、あ
るいはそれらの変性体、あるいは他の多官能アクリル樹
脂との混合体であり、特許請求範囲第1項に記載の可視
光線硬化型ギプス。 3、前記光重合開始剤はそのもの自体あるいは助剤の共
存下で波長が380−550ミリミクロンでラジカル開
始剤として機能するものをいい勿論紫外線領域でも開始
剤機能を示すものであっても良い、このものが添加され
た特許請求範囲第1項に記載の可視光線硬化型ギプス。 4、前記補強材としては、ガラス繊維、合成繊維、木綿
繊維等を各種形状に織られたものであり、特許請求範囲
第1項に記載の可視光線硬化型ギプス。 5、架橋型樹脂組成物、各種補強材との組み合わせによ
るギプス用素材が光遮閉能のある袋状物に包装されて保
存性をもたせた、特許請求範囲第1項に記載の可視光線
硬化型ギプス。
[Claims] 1. A radical initiator and an auxiliary agent having the function of curing with visible light are mixed into a crosslinked resin that cures by a radical reaction, and various fibrous reinforcing materials are impregnated with this kind of resin composition, Visible light-curable resin casts are used by irradiating light in a range that is harmless to the human body for a short period of time, such as wavelengths of 380-550 millimicrons, to harden and mold the resin into the desired shape. 2. The visible light-curable cast according to claim 1, wherein the crosslinked resin is an epoxy acrylate resin, a modified product thereof, or a mixture with another polyfunctional acrylic resin. 3. The photopolymerization initiator itself or in the presence of an auxiliary agent is one that functions as a radical initiator at a wavelength of 380 to 550 millimicrons, and of course may also exhibit an initiator function in the ultraviolet region. A visible light-curable cast according to claim 1, to which this material is added. 4. The visible light-curable cast according to claim 1, wherein the reinforcing material is made of glass fibers, synthetic fibers, cotton fibers, etc. woven into various shapes. 5. Visible light curing according to claim 1, in which a cast material made of a combination of a crosslinked resin composition and various reinforcing materials is packaged in a bag-like material with light-blocking ability to provide preservability. mold cast.
JP60182530A 1985-08-20 1985-08-20 Visible light curable medical gypsum Pending JPS6244259A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60182530A JPS6244259A (en) 1985-08-20 1985-08-20 Visible light curable medical gypsum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60182530A JPS6244259A (en) 1985-08-20 1985-08-20 Visible light curable medical gypsum

Publications (1)

Publication Number Publication Date
JPS6244259A true JPS6244259A (en) 1987-02-26

Family

ID=16119915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60182530A Pending JPS6244259A (en) 1985-08-20 1985-08-20 Visible light curable medical gypsum

Country Status (1)

Country Link
JP (1) JPS6244259A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147433A (en) * 1990-02-15 1992-09-15 At&T Bell Laboratories Methods of making coated optical fiber
JP2016130281A (en) * 2015-01-13 2016-07-21 株式会社カネカ Shock absorbing member manufacturing method and shock absorbing member

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147433A (en) * 1990-02-15 1992-09-15 At&T Bell Laboratories Methods of making coated optical fiber
JP2016130281A (en) * 2015-01-13 2016-07-21 株式会社カネカ Shock absorbing member manufacturing method and shock absorbing member

Similar Documents

Publication Publication Date Title
US3908644A (en) Lightweight orthopedic cast material
US3421501A (en) Method and application of orthopedic appliances with an ultraviolet curable plastic impregnated bandage
US3089486A (en) Orthopedic structures, and methods and compositions for making same
US20070004993A1 (en) Reinforced low temperature thermoplastic material
US4512340A (en) Visible light cured orthopedic polymer casts
JP3796120B2 (en) Molded body from polyurethane material, and production method and use thereof
WO2007035875A2 (en) Reinforced low temperature thermoplastic material
DE69535000T2 (en) Container for storing gel
RU94044443A (en) Means for adhesive plaster bandage, wound bandages, surgical sheet or suture, flexible sheet of elastomer material, rubber band for use in oral cavity, suture, tooth brush, thread for cleaning interdental spaces
RU97115816A (en) POLYMER-FIBERED BREAK, METHOD FOR ITS OBTAINING, AND ALSO APPLICATION OF THE SPECIFIED BREAK
JPH0352295B2 (en)
WO2018089663A1 (en) Light-curable fixation composites and systems for orthopedic stabilization
JPS6244259A (en) Visible light curable medical gypsum
US3618599A (en) Orthopedic device having a resin curable by ultrasonic energy
JPS6238168A (en) Visible light curable medical gypsum
US2703776A (en) Method of bonding fabric to another surface
DE3734472A1 (en) MATERIAL PACK FOR THE PRODUCTION OF PLATE TOOTH PROSTHESES
JPS63162769A (en) Cavity liner
DE4446650A1 (en) Artificial finger nail and nail prosthesis prodn.
NZ231909A (en) Transdermal therapeutical system comprising norpseudoephedrine in an adhesive polymeric reservoir layer
JP2002291861A (en) Plaster cast material
JPH0791171B2 (en) Photocurable resin composite composition for straightening
JP3732405B2 (en) Synthetic rigid bandage
JP3566723B2 (en) Orthopedic materials
JPS63183904A (en) Visible light polymerization-curable composition